Results 151 to 160 of about 224,404 (241)

Hormonal remodeling and molecular mechanisms in postmenopausal osteoporosis: Pathogenesis and therapeutic implications (Review). [PDF]

Int J Mol Med
Liu W, Li Z, Wang P, Zeng J, Zeng H, Xie Y, Yang R, Yang L, Lin S, Zhang C.   +9 more
europepmc   +1 more source

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis

, 2002
The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) and quality of life of women with postmenopausal osteoporosis.
İ. Dalkıran, F. Taşçıoğlu, C. Öner, E. Sırmagül, O. Armağan   +4 more
core  

Higher Bone Mineral Density in Obesity Masks Impaired Bone Remodeling and Disproportionate Musculoskeletal Adaptation in Young Women

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Women with obesity exhibited higher total and site‐specific BMD and greater lean mass than lean controls. However, reduced BMD‐to‐fat and lean‐to‐fat mass ratios, increased CTX1 and RANK‐L/OPG, and decreased P1NP and osteocalcin indicated impaired bone remodeling, suggesting that increased BMD masks altered bone turnover and compromised skeletal health.
Yasmin Silva Forte, Caio Andrade‐Santos, Camila Pantoja‐Marinho, Luísa González‐Joaquim, Aline Penna‐De‐Carvalho, Paulo Roberto Falcão Leal, Karynne Grutter Lopes, Luiz Guilherme Kraemer‐Aguiar, Christina Barja‐Fidalgo   +8 more
wiley   +1 more source

Healthy Eating Index and Bone in Obesity. [PDF]

Curr Osteoporos Rep
Sukumar D, Alsayed EA.
europepmc   +1 more source

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation

, 2009
Aim: Comparison of the effectiveness of strontium ranelate (SR) and alendronate sodium (AS) on bone mineral density (BMD) in postmenopausal osteoporosis. Material and Methods: A total of 41 patients were included in the study. 2 gr/day SR was applied a
Sibel Ünsal Delialioğlu, Sumru Özel, Eda Kurt, Sezen Özgönül, Kurtuluş Kaya, Canan Çulha   +5 more
core  

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation

, 2012
Plamen Kinov1, Mihail Boyanov21Department of Orthopedics and Traumatology, University Hospital Queen Giovanna – ISUL, 2Department of Internal Medicine, Clinic of Endocrinology, University Hospital Alexandrovska, Medical University of Sofia ...
Kinov P, Boyanov M
core  

Comments on: Knowledge and practices of postmenopausal women regarding vitamin D and osteoporosis. [PDF]

Rev Bras Ginecol Obstet
Avalos CJR, Cabrejo BER, Fernández GC.
europepmc   +1 more source

Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity. [PDF]

Aging Med (Milton)
Rajan R, Cherian K, Paul T, Asha HS, Jose A, Rebekah G, Thomas N, Kapoor N.   +7 more
europepmc   +1 more source

Treatment options for postmenopausal osteoporosis

, 2012
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United KingdomTo serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again
Walsh GM
core  

Effect of Transcutaneous Electrical Acupoint Stimulation on Postmenopausal Osteoporosis-Related Pain: Study Protocol for a Randomized, Sham-Controlled Trial. [PDF]

J Pain Res
Yan S, Wang X, Pan F, Ni W, Luo N, Hu G, Qin X, Ding C, Lu C, Chen N.   +9 more
europepmc   +1 more source